AAPL vs ALLO · P/E 39, rev $416.16B vs rev $22.0K
Apple Inc (AAPL) versus Allogene Therapeutics Inc (ALLO) — a side-by-side from cached financials, not a winner call.
Apple Inc (AAPL) is a consumer electronics company listed on US. It is led by Tim Cook.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Latest reported AAPL revenue for 2025-09-27 was $416.16B. Net income was $112.01B. AAPL currently screens at market cap $3.83T and trailing P/E 39.2.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
AAPL currently screens at market cap $3.83T and trailing P/E 39.2. ALLO currently screens at market cap $258.1M.
Not investment advice. Open the AAPL and ALLO stock pages for the full models.
Not investment advice.